missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CD155/PVR Antibody (S04-2C7), Novus Biologicals™
  7. 18613884

CD155/PVR Antibody (S04-2C7), Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-19998-50ul

 View more versions of this product

Product Code. 18613884

  • € 444.00 / 50µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD155/PVR Monoclonal antibody specifically detects CD155/PVR in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin)
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD155/PVR
Monoclonal
0.3 mg/mL
Western Blot, Immunohistochemistry 1:50, Immunohistochemistry-Paraffin
CD155, CD155 antigen, HVED, NECL5, NECL-5, nectin-like 5, Nectin-like protein 5, poliovirus receptor, PVSFLJ25946, Tage4
Recombinant protein of human CD155/PVR (Uniprot # P15151)
50 μg
Virology Bacteria and Parasites
5817
Store at 4°C short term. Store at -20°C long term. Avoid freeze-thaw cycles.
IgG
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin)
S04-2C7
Unconjugated
50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40% Glycerol, 0.05% BSA
Rabbit
Affinity purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.